Just me for this episode. I give a short run down of the evidence for anticoagulation for AF in patients with end stage renal failure who are on dialysis. Here are some links to the articles mentioned in the episode: 1) Randhawa et al (2020). Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease. A Systematic Review and Meta-analysis https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2763969 2)Siontis et al. (2018) Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.035418 3)Königsbrügge O et al (2019). Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781927/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related